Roche
Roche to acquire Foundation Medicine in a $1-bn deal
13 Jan 2015
Roche, the world's largest seller of cancer drugs, is acquiring over half of biotechnology diagnostics researcher Foundation Medicine, in a deal valued at $ 1 billion
Roche to buy InterMune for $8.3 bn
25 Aug 2014
The purchase of InterMune, a developer of a drug for pulmonary fibrosis, would add $1 billion in global sales for Roche by 2019
May collaborate, not take over Roche: Novartis
03 Mar 2014
Novartis, which holds a third of Roche's bearer shares, has once again scotched reports of acquiring its Swiss rival, Roche
.webp)
